NASDAQ: RLYB
Rallybio Corp Stock Ownership - Who owns Rallybio?

Insider buying vs selling

Have Rallybio Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Stephen UdenCEO2026-10-2733,244$6.08
$202.12kBuy
Jonathan I. LieberCFO2026-10-27599$16.04
$9.61kSell
Wendy ChungDirector2026-10-262,062$15.28
$31.51kBuy
Helen M. BoudreauDirector2026-10-162,062$15.28
$31.51kBuy
Paula SoteropoulosDirector2026-10-163,562$2.38
$8.48kBuy
Robert Lorne HopfnerDirector2026-10-122,062$15.28
$31.51kBuy
Robert Lorne HopfnerDirector2026-10-123,562$2.38
$8.48kBuy
Robert Lorne HopfnerDirector2026-10-129,196$7.60
$69.89kBuy
Jonathan I. LieberCFO2026-10-093,910$6.08
$23.77kBuy
Stephen UdenCEO2026-10-0622,456$6.08
$136.53kBuy

1 of 3

RLYB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RLYB insiders and whales buy or sell their stock.

RLYB Shareholders

What type of owners hold Rallybio Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kush Parmar193.09%10,396,074$166.23MInsider
5am Opportunities I LP118.42%6,375,811$101.95MInsider
Ronald Hunt79.78%4,295,514$68.69MInsider
Viking Global Investors LP77.91%4,194,777$67.07MInsider
Robert Lorne Hopfner73.86%3,976,619$63.59MInsider
5am Partners V LLC67.44%3,630,724$58.06MInsider
5am Ventures V LP51.72%2,784,626$44.53MInsider
Timothy M. 1. Shannon44.76%2,409,712$38.53MInsider
Adar1 Capital Management LLC17.21%926,352$14.81MInsider
Martin MacKay13.36%719,126$11.50MInsider

1 of 3

RLYB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RLYB0.01%99.99%Net BuyingNet Buying
CRBP0.07%76.94%Net SellingNet Selling
RANI0.03%45.57%Net BuyingNet Selling
NTHI0.01%99.99%Net BuyingNet Buying
CLLS0.01%0.00%

Rallybio Stock Ownership FAQ

Who owns Rallybio?

Rallybio (NASDAQ: RLYB) is owned by 0.08% institutional shareholders, 752.47% Rallybio insiders, and 0.00% retail investors. Kush Parmar is the largest individual Rallybio shareholder, owning 10.40M shares representing 193.09% of the company. Kush Parmar's Rallybio shares are currently valued at $160.20M.

If you're new to stock investing, here's how to buy Rallybio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.